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Short Summary 
A study of boys’ intention to receive HPV vaccination found that community intervention is 
essential to educate parents consenting to HPV vaccination for boys at a young age. 
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Abstract 
Background: The aim of this study was to investigate factors associated with the willingness 
of boys to accept the human papillomavirus (HPV) vaccine.  
Methods: A nationwide cross-sectional survey among Secondary One male students in 
Malaysia. 
Results: Among 2823 respondents, knowledge about HPV infection and the HPV vaccine was 
extremely poor. The mean total knowledge score was only 3.17 (SD ± 2.14), out of a possible 
score of 10. The majority of respondents were unaware that vaccinating boys can help protect 
girls against HPV infection (81.6%), and HPV is a sexually transmitted infection (70.1%). 
Many had the misconception that only females get HPV (78.9%). In  multivariable analysis, 
the factors associated with the intention to receive the HPV vaccination were: agreeing boys 
need to be vaccinated against HPV infection (OR = 2.05, 95% CI: 1.57 - 2.68), perceiving 
their parents might allow them to get the HPV vaccine (OR = 1.66, 95% CI: 1.18 - 2.34), 
perceived susceptibility to HPV infection (OR = 1.63, 95% CI: 1.06 - 2.52), and attending a 
rural school (OR = 1.49, 95% CI: 1.14 - 1.95). 
Conclusions: Public health educational programs that are focused and tailored on parents 
consenting to HPV vaccination for boys at a young age can be useful in improving HPV 
vaccination rates among boys. There is also a pressing need to educate boys about the benefits 
of HPV vaccination in males and about HPV disease susceptibility to facilitate adoption of the 
HPV vaccine by young adults in the future. 
Keywords 
HPV, HPV vaccination, boys 
AC
CE
PT
ED
4 
Introduction 
HPV, being the most common sexually transmitted infection, is well known for its association 
with various cancers affecting women including cervical, vaginal, and vulval cancers
1,2
.
However, HPV is also associated with male cancers of the penis, anus and oropharynx
2
. The
benefit of the HPV vaccine in boys has been understressed as the initial focus and marketing 
of the HPV vaccine targeted prevention of cervical cancer among women
3
. The National
Health and Nutrition Examination Survey (NHANES) 2013 - 2014 reported that the overall 
genital HPV infection prevalence among 1868 men was 45.2%
4
. Although the clinical
benefits of vaccinating boys have been clearly demonstrated
5
, one of the most debated issues
is the cost effectiveness of universal vaccination. In 2011, it was reported that including boys 
in a vaccination programme is especially advisable if vaccine coverage of girls is low
6.
However, even in countries with high female coverage there are advantages to vaccinating 
males. For example, gender-neutral vaccination protects men who have sex with men (MSM) 
who may not benefit from the herd protection provided by a female-only program. High 
prevalence of penile and anal HPV infection among teenage MSM
7
, and in addition to HPV
vaccine hesitancy associated to same-sex behavior stigma
8
 further imply the importance of
universal HPV vaccine coverage of boys. Also, the goal of cervical cancer elimination, 
endorsed by the World Health Organization, can be achieved more quickly when high rates of 
vaccination of both males and females can be achieved
9
. Therefore, the extension of HPV
vaccination to boys is anticipated to become more generally recommendedin the near future, 
particularly when there is low vaccination coverage in women. Vaccinating boys and girls 
against HPV infection may put Malaysia on the path towards achieving the elimination of 
cervical cancer.  
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In 2009, the quadrivalent HPV vaccine (4vHPV; Gardasil) was licensed in the USA by the 
FDA for males aged 9 through 26
6
.  In 2011, the US Advisory Committee on Immunisation
Practices recommended routine use of 4vHPV for boys aged 11–12 years, with routine catch-
up vaccination through age 21
6
. For males, 4vHPV and the more recently licensed 9-valent
vaccine (9vHPV) are approved for prevention of genital warts and anal cancers and pre-
cancers. To date,  public HPV vaccine programs are now including males in many countries 
including Canada
10
, Austria
11
, and Austalia
12
.
U.S. studies indicate that HPV vaccine uptake in boys continues to lag behind female 
vaccination rates, despite the CDC’s recommendations and the demonstrated efficacy of the 
vaccine
6,13
. Therefore, understanding how to promote the HPV vaccination of boys is a public
health priority. The Health Belief Model (HBM) is a useful theoretical construct to understand 
the influence of behaviors related to HPV vaccine uptake. This model is based on the 
assumption that individuals facing a particular diseases or threat evaluate their susceptibility 
to the problem and its severity, and then base their decision to take action on the perceived 
benefits and barriers of different actions
 14,15
.  Previous studies have shown that perceived
severity
16
 and perceived susceptibility of HPV infection
17
 had a positive effect on the
intention to obtain an HPV vaccination. Additionally, previous studies also found that 
adolescent males with less HPV knowledge had higher levels of shame and were less likely to 
engage in preventive health behaviours, including HPV vaccination
18,19
.
The 4vHPV has also been approved and recommended for males in Malaysia. However, in 
Malaysia, studies on HPV vaccine acceptability have  focused on women and relatively few 
have focused on men or boys. There was one small scale study that surveyed both boys and 
girls in rural areas of a state in Malaysia. This study found that there were no significant 
differences between boys and girls in willingness to be vaccinated against HPV infection
20
.
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Large-scale study on HPV vaccine uptake rates and willingness to receive the HPV vaccine 
specifically in boys have never been conducted in Malaysia. The Malaysian government has 
implemented the National HPV immunization programme since 2010, supplying HPV 
vaccine free to all Secondary One (13 year old) female students including in rural areas at no 
charge, upon getting parental consent; however, boys are not included in this program. The 
HPV immunization program in Malaysia has been widely accepted since it was introduced, 
with more than 95% participation among female students each year
21
. During the data
collection period of this study, the HPV vaccine has not been recommended for boys. Since 
the HPV vaccine is approved by the FDA for the use in males in year 2018, the HPV vaccine 
is now available for boys in Malaysia. We have previously surveyed Secondary One female 
students about their level of knowledge and attitudes to HPV vaccination (findings have been 
submitted for publication). In this study, we report findings of our survey of male students 
about their knowledge, health beliefs about HPV infection and vaccinaton, and the factors 
associated with their willingness to accept the HPV vaccine. 
Materials and Methods 
Study participants 
Simple random sampling was used to select 2 secondary schools (each from urban and rural) 
from all the 13 states and 3 federal territories in Malaysia, giving a total of 32 schools where 
the nationwide survey was conducted. All Secondary One Malaysian male students in the 
sampled schools were approached to participate. The paper-based questionnaire was 
administered to the students between February 2013 and April 2013 in their classroom guided 
by teachers and research assistants. 
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Instruments 
A standardized questionnaire was given to each student. The questionnaire assessed 
demographic characteristics, and knowledge and health beliefs related to HPV infection and 
vaccination. In the knowledge section, respondents were asked a series of questions regarding 
HPV infection, its relationship to cervical cancer and genital warts, HPV vaccine and the 
effectiveness of the HPV vaccine (10 item scales). Response options were ‘true’, ‘false’ and 
‘don’t know’. A correct response was given a score of 1, and an incorrect or ‘don’t know’ was 
scored as 0. The possible total knowledge score ranged from 0 to 10, with higher scores 
representing higher levels of knowledge. 
The second section of the questionnaire assessed respondents’ health beliefs regarding HPV 
vaccination, using the HBM constructs as a theoretical framework
16
. Questions included
general heath beliefs (2 items), perceived benefits of HPV vaccine (1 item), perceived 
susceptibility to HPV (1 item), concerns about getting infected with HPV (1 item) and 
perceived severity of HPV infection (1 item). Response options were ‘agree’, ‘don’t know’ 
and ‘disagree’. 
The third section of the questionnaire assessed the attitude of respondents towards HPV 
vaccination (7 items). Seven statements were presented, with response options of ‘agree’, 
‘don’t know’ and ‘disagree’. 
The questionnaire was in 3 languages: Bahasa Malaysia (Malay), Chinese and English, and
was pretested before commencing the study. At each selected school, a survey administrator 
was appointed and briefed on how to correctly administer the survey questionnaires.
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Pretesting and validation of study instruments 
The questionnaire was content validated by 3 panel experts to ensure the relevance and clarity 
of the questions. After minor amendments, the questionnaire was pilot tested on 20 randomly 
sampled students who were not included in the main study. Pilot test participants were 
included from the 3 main ethnic groups, Malays, Chinese and Indians. The questionnaire was 
revised again based on student comprehension. Subsequently, the questionnaire was construct 
validated on 150 randomly selected students and factor loading was calculated to indicate the 
level of each specific knowledge item. The internal consistency (Cronbach’s alpha) of the 
score for knowledge items was found to be 0.755. After 2 weeks, test-retest reliability was 
assessed on a subsample of 80 of the same participants, and found to be 0.3 - 0.6, with most 
kappa values > 0.1. Based on the outcome of the construct validity and test-retest assessments, 
the questionnaire was revised again before the start of the actual study. 
Ethical considerations 
This study was approved by the Medical Ethics Committee at the University of Malaya 
Medical Centre, Kuala Lumpur, Malaysia and the Ministry of Education, Malaysia (reference: 
number 968.3). Written permission was obtained from the State Education Department in 
each of the states and federal territories in Malaysia. Written permission was also obtained 
from the principals of the selected schools. Students were informed that their participation 
was voluntary. Students who agreed to answer the survey questions were asked to sign an 
informed consent form.  All responses were collected and analyzed without identifiers. AC
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Statistical analysis 
All statistical analyses were performed with Statistical Package for the Social Sciences, 
version 20.0 (IBM Corp., Armonk, NY, USA). The significance level was set at p < 0.05. 
Mean values with standard deviations (SD) or medians with interquartile ranges (IQR) were 
calculated for continuous variables, while frequencies were counted for categorical variables. 
Multivariable logistic regression analysis of factors involved in intention to take HPV 
vaccination was performed. All variables found to have a statistically significant association 
(two-tailed p-value < 0.05) with intention to take HPV vaccination in the univariate analyses 
were included in the logistic-regression model. 
Results 
Characteristics of participants 
A summary of the characteristics of the respondents is provided in Table 1. A total of 2823 
responses were received, a response rate of 83.0%. There were no significant differences in 
response rate by states and urban-rural localities. Most of the respondents were Malay 
(63.3%), followed by Chinese (23.4%) and Indian (4.8%), which is similar to the national 
distribution of ethnicities. More than half of the participants were Muslims (66.2%), followed 
by Buddhists (19.6%), Christians (8.3%), Hindus (3.9%), and Taoists (1.7%). A total of 73.6% 
reported being moderately religious, while 22.7% were very religious, and 3.7% were not 
religious at all. The majority of respondents’ mothers were housewives (61.8%), while the
majority of their fathers were employed as managers (39.5%) and skilled workers (37.9%). 
Slightly over half of the respondents (54.9%) were from households with a monthly income
below MYR 2000 (USD 450). The majority of the schools were located in an urban setting 
(63.9%). 
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Source of HPV or HPV vaccination information 
Slightly over half of participants had never heard of HPV or HPV vaccination (n = 1614, 
57.2%). As shown in Table 1, a significantly higher proportion of participants with mothers in 
professional occupations (56.4%) reported having heard of HPV or HPV vaccination than 
those with mothers in other occupations. Likewise, a significantly higher proportion of 
participants with fathers in professional occupations (48.2%) also reported having heard of 
HPV or HPV vaccination than those with fathers in other occupations; although, participants 
with fathers who were unemployed showed the highest proportion (50.6%) of those who had 
heard of HPV vaccination. Participants from schools in urban areas (44.7%) were 
significantly more likely to have heard of HPV or HPV vaccination compared to those from 
rural areas (39.5%). 
Among those who had heard of HPV or HPV vaccination, the most common sources of 
information were TV or radio (46.9%) and their teacher (43.7%). Other sources in order were: 
newspaper or magazine (30.6%), doctor (20.8%), peers (20.0%) and the internet (16.5%; 
Figure 1). 
Knowledge about HPV or HPV vaccination 
Figure 2 shows the proportion of correct responses on knowledge items among participants 
who had heard of HPV or HPV vaccination. Only 2 knowledge items were correctly answered 
by over half of the respondents, namely vaccines are available to prevent HPV infection 
(58.1%) and HPV infection could be asymptomatic (56.2%). Only 21.1% knew that males 
could also get HPV infection. An even lower proportion was aware that vaccinating boys 
could protect girls against HPV infection (18.4%) and that HPV could not be cured (17.8%). 
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The mean total knowledge score was 3.17 (SD ± 2.14) out of a possible score of 10. The 
median was 3 (inter quartile range, IQR, 1 - 5).  
Health beliefs regarding HPV and HPV vaccination 
Approximately half (49.6%) of respondents believed that the HPV vaccine is good for one’s 
health just like all other vaccines, and 55.6% believed that taking the HPV vaccine is a good 
idea as it is recommended by the government. Nearly two-thirds of respondents (60.7%) 
believed that the HPV vaccination is beneficial. Only 9.3% of respondents felt that they were 
susceptible to getting infected with HPV. Only 39.9% were worried about getting infected 
with HPV and 43.6% had the belief that infection with HPV can lead to serious illness.  
Attitudes towards HPV vaccination 
Table 3 represents respondents’ attitudes towards HPV vaccination. A total of 40.1% agreed 
with the statement, boys do not need to be vaccinated, only girls should receive the HPV 
vaccine. A minority (15.6%) believed that the HPV vaccine is not safe. Only 16.8% thought 
that HPV vaccine will not prevent HPV infection. A small proportion agreed with the 
statements that HPV vaccines may encourage people to have sex at an early age (12.0%), 
encourage people to have multiple sexual partners (11.2%), and my parents might not allow 
me to get the HPV vaccine (15.4%). Only 8.6% noted my religion prohibits me from receiving 
the HPV vaccine because it is sex-related. Further analysis showed that there were no 
significant differences in the response across religions. 
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Intention to receive HPV vaccination 
In total, less than half (48.4%, n = 1366) reported that they were likely to receive the HPV 
vaccination. As shown in Table 4, variables that were significantly associated with an 
intention to receive HPV vaccination in the univariate analysis were age, ethnicity, religion, 
location of school, perceived benefit, perceived susceptibility, perception that boys need HPV 
vaccine, and parental prohibition to vaccination. From the multivariable logistic regression 
model, the only 4 significant predictors of intention to receive HPV vaccination were rural 
location of school (OR = 1.49, 95% CI: 1.14 - 1.95), higher perceived susceptibility to HPV 
(OR = 1.63, 95% CI: 1.06 - 2.52), perception that boys need HPV vaccine (OR = 2.05, 95% 
CI: 1.57 - 2.68), and the perception that their parents would allow them to get the HPV 
vaccine (OR = 1.66, 95% CI: 1.18 - 2.34). 
Discussion 
This nationwide cross-sectional survey recruited samples of students with diverse 
backgrounds. The finding that a higher proportion of boys whose parents work in professional 
occupations reported having heard of HPV or HPV vaccination, implies a need to tailor 
education intervention to lower occupational groups. The low mean knowledge score 
indicates that the level of knowledge about HPV and HPV vaccination among boys in this 
study was inadequate. Clearly, such knowledge deficits need to be addressed. While it is 
important that the current HPV vaccination program in Malaysia focuses on reducing the 
incidence of cervical cancer among women by giving the HPV vaccine to girls, boys should 
not be neglected. Briefings about HPV and the HPV vaccine given along with the HPV 
vaccination to the girls by the healthcare team should be extended to include boys to enable 
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them to take precautionary measures against HPV infection and better equip them to make 
decisions regarding vaccination in the future
22
. Ideally, education tailored for male students
should be introduced in schools, communicating to them that HPV infection and diseases are 
issues for both males and females. Although males are not included in the HPV vaccination 
program, they can still get the vaccine from private health care providers. Nevertheless, cost 
would be the major barrier to the uptake of the HPV vaccine in private settings. Currently, the 
3-dose HPV vaccines would cost about RM600 to RM700 (USD140 to USD160) if obtained
in private clinics in Malaysia. Subsidizing the costs for vaccination would likely  raise HPV 
vaccine uptake among the boys. 
The study found that the preceived susceptibility to HPV infection among boys was extremely 
low. Such a viewpoint potentially threatens adolescent boys’ sexual health, as it potentially 
promotes a neglect of prevention behaviors. As a result, to promote HPV prevention, the high 
risk of HPV infection among sexually active young adults should be emphasized to adolescent 
boys in the future. Furthermore, the low perceived severity of HPV infection found in this 
study also requires attention. Mass media in Malaysia have framed their promotion of HPV 
vaccine for cervical cancer prevention, but have lacked focus with regard to the consequences 
of HPV infection in men. The public, especially men, need to know that male HPV infection 
is an important concern, both for the disease burden in men and for the risk of transmission to 
women. The general population should understand that HPV infections in men are also 
associated with a variety of cancers, including anal, penile and oral. The fact that the 
incidence of anal and oral cancers related to HPV is increasing in the general population 
worldwide
23,24 
should be made known to the public along with publicity for HPV vaccination
of males in Malaysia. 
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Another important finding that needs attention was the erroneous belief that boys do not need 
to be vaccinated, and that only girls should receive the HPV vaccine. The HPV vaccine 
should not be promoted purely for prevention of cervical cancer among women but also to 
prevent consequences of HPV infection on men. The current implementation age of HPV 
vaccination in Malaysia is for  13 year old Secondary One girls, given according to a 3-dose 
protocol. The program has been very successful, having achieved 98% coverage
25
. Although
including boys in a vaccination programme is thought to be a lower priority with high 
coverage among girls
6
, communication with patients should highlight the benefits of HPV
vaccination to boys in terms of preventing HPV-related diseases among males. In addition, 
the ultimate goal of cervical cancer elimination can be achieved more quickly with a gender-
neutral vaccination policy. 
Multivariable  analysis showed that intention to receive the HPV vaccination was influenced 
by preceived parental approval for vaccination. Therefore, educating parents in the 
community at large about vaccinating middle school boys against HPV infection is essential. 
In addition, the attitudes of health care providers towards recommending the HPV vaccine for 
males is important
26
. Our previous study revealed a physician’s recommendation as the key
factor that influenced parents as to the vaccination of their sons aged 11 - 18 years old
27
.
Perceived susceptibility in the HBM can be used as a framework to guide design for 
enhancing HPV vaccine uptake among males in Malayisa as it is found to be significantly 
associated with intention to receive the HPV vaccine in this study. In a recent study, perceived 
susceptibility was also found to be significantly associated with HPV vaccine uptake among 
men who have sex with men
28
. It has been noted that men were not motivated to get
vaccinated when they lacked a sense of vulnerability or susceptibility to HPV infection
26,28
.
Multivariable anlysis also showed that boys from rural schools were significantly more likely 
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to express an intention to receive the HPV vaccine. The reason for the urban-rural disparity in 
intention to receive the HPV vaccine is unknown. Such findings warrant further investigation, 
as an understanding of the disparity will help in designing targeted HPV vaccination policies 
for rural and urban children. 
An important implication from this study is the that the strategies to improve HPV vaccine 
uptake should include emphasizing educating the parents in the community about the 
importance of HPV vaccination in boys and the high prevalence of HPV in all sexually active 
adolescents. Of note, although evidence supporting the efficacy of educational intervention in 
promoting HPV vaccine uptake is lacking
29,30
 there is sufficient evidence suggesting that 
educational interventions improve the general public’s knowledge about HPV and cervical 
cancer
31
,  intention to receive the HPV vaccination and their ability to make informed 
decisions
29,32
. Therefore, in addition to imparting education, it is also imporant to promote 
vaccine uptake such as provision of financial subsidies for HPV vaccination of boys. 
The limitations of the study are that only Secondary One boys averaging 13 years of age were 
surveyed, and data collection was cross-sectional and based on self-reporting of data. Of note 
willingness to receive the vaccine does not necessarily result in receiving the vaccine. 
Although an individual may be willing to receive HPV vaccine, there are several factors that 
may prevent them from doing so, such as cost or logistic barriers, that are not investigated in 
this study. Further investigation of these factors in future studies is warranted. Despite these 
limitations the sample was large and extended to all states of Malaysia, covering urban-rural 
locality, thus offering good generalizability. The distribution of average household income in 
this study closely represent to income distribution of general population in Malaysia in the 
year of data collection further strengthen the national representativeness of the data. 
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This study underscores the need for educational interventions to enhance the HPV vaccine-
related knowledge among boys to highlight the advantages of HPV vaccination for males. 
While adolescent boys may recognize that HPV causes cervical cancer in women, the severity 
of HPV infection in men and the benefits of HPV vaccination for males, including prevention 
of HPV infection in females, are relatively less-known and should be the target of educational 
intervention. To promote HPV vaccination in males, educational programming targeting 
males should address health beliefs and emphasize susceptibility to infection. Public health 
educational programs should also be focused on parents who must consent to HPV 
vaccination for boys at a young age. 
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Figure 2 Correct responses on knowledge items (N=1209) 
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Table 1 Distribution of sociodemographic characteristics of the respondents (n = 2823) 
 Overall 
N (%) 
Heard of HPV or HPV 
vaccination? 
2 
p-value 
 Yes 
(n = 1209) 
No 
(n = 1614) 
 
Sociodemographic characteristics     
Age (years old)     
13 2699 (95.6) 1182 (43.8) 1517 (56.2) p<0.000 
  14 124 (4.4) 27 (21.8) 97 (78.2)  
Ethnicity     
  Malay 1788 (63.3) 857 (47.9) 931 (52.1)  
  Chinese 661 (23.4) 182 (27.5) 479 (72.5) p<0.000 
  Indian 131 (4.6) 58 (44.3) 73 (55.7)  
  Aborigines  211 (7.5) 103 (48.8) 108 (51.2)  
  Others 32 (1.1) 9 (28.1) 23 (71.9)  
Religion     
  Islam 1869 (66.2) 911 (48.7) 958 (51.3)  
  Buddhism 552 (19.6) 149 (27.0) 403 (73.0)  
  Taoism 49 (1.7) 18 (36.7) 31 (63.3) p<0.000 
  Hinduism 109 (3.9) 50 (45.9) 59 (54.1)  
  Christianity 234 (8.3) 79 (33.8) 155 (66.2)  
  Others 10 (0.4) 2 (20.0) 8 (80.0)  
Religious status
 ‡
     
  Very religious 632 (22.7) 291 (46.0) 341 (54.0)  
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  Moderately religious 2046 (73.6) 862 (42.1) 1184 (57.9) 0.102 
  Not at all religious 103 (3.7) 38 (36.9) 65 (63.1)  
Mother’s Occupation ‡     
  Professional 342 (12.8) 193 (56.4) 149 (43.6)  
  Managerial 466 (17.5) 194 (41.6) 272 (58.4) p<0.000 
  Skilled worker 217 (8.0) 96 (44.2) 121 (55.8)  
  Housewife 1657 (61.8) 692 (41.8) 965 (58.2)  
Father’s occupation ‡     
Professional 488 (19.4) 235 (48.2) 253 (51.8)  
  Managerial 992 (39.5) 434 (43.8) 558 (56.2) 0.028 
  Skilled worker 950 (37.9) 386 (40.6) 564 (59.4)  
  Unemployed 79 (3.1) 40 (50.6) 39 (49.4)  
Monthly average household income 
(MYR) 
‡ 
 
    
  ≤ 1000 858 (31.9) 369 (43.0) 489 (57.0)  
  1001 - 2000 617 (23.0) 261 (42.3) 356 (57.7)  
  2001 - 3000 407 (15.1) 182 (44.7) 225 (55.3) 0.355 
  3001 - 4000 319 (11.9) 134 (42.0) 185 (58.0)  
  > 4000 486 (18.1) 232 (47.7) 254 (52.3)  
Location of school     
  Urban 1805 (63.9) 807 (44.7) 998 (55.3) 0.007 
  Rural 1018 (36.1) 402 (39.5) 616 (60.5)  
‡
Number less than total number of respondents due to lower response rate 
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Table 2. Health beliefs regarding HPV and HPV vaccination. 
† 
Number of respondents less than 1,209 (total respondents) due to non-response 
Health belief  n
 †
 Agree Disagree Don’t know 
General health belief  n (%) n (%) n (%) 
HPV vaccine is good for health like other 
vaccines  
1181 586 (49.6) 128 (10.8) 467 (39.5) 
Taking the HPV vaccine is a good idea 
because it is recommended by the 
government  
1179 656 (55.6) 119 (10.1) 404 (34.3) 
Perceived benefit     
The HPV vaccine would be a good way 
to prevent HPV infection  
1182 717 (60.7) 80 (6.8) 385 (32.6) 
Perceived susceptibility     
Do you think you will get infected with 
HPV?  
1183 110 (9.3) 326 (27.6) 747 (63.1) 
Feeling of worry     
I am worry about getting infected with 
HPV  
1182 472 (39.9) 268 (22.7) 442 (37.4) 
Perceived severity     
Infection with HPV can lead to serious 
illness  
1183 516 (43.6) 114 (9.6) 553 (46.7) 
Perceived barriers     
Getting vaccines is scary and painful  1183 259 (21.9) 307 (26.0) 617 (52.2) 
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Table 3 Attitudes regarding HPV vacccination 
Attitude  n Agree Disagree Don’t know 
  n (%) n (%) n (%) 
Attitudes      
Boys do not need to be vaccinated, only 
girls should receive the vaccine 
1181 474 (40.1) 200 (16.9) 507 (42.9) 
The HPV vaccine is not safe for me  1180 184 (15.6) 346 (29.3) 650 (55.1) 
I don’t think the HPV vaccine will 
prevent HPV infection  
1175 197 (16.8) 423 (36.0) 555 (47.2) 
The HPV vaccine may encourage 
peeople to have sex at an early age 
1179 142 (12.0) 337 (28.6) 700 (59.4) 
The HPV vaccine may encourage people 
to have multiple sexual partners 
1177 132 (11.2) 343 (29.1) 702 (59.6) 
My parents might not allow me to get the 
HPV vaccine  
1180 184 (15.6) 280 (23.7) 716 (60.7) 
My religion prohibits me from receiving 
the HPV vaccine because it is sex-related  
1180 101 (8.6) 373 (31.6) 706 (59.8) 
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Table 4 Multivariable logistic regression analysis of factors involved in intention to receive HPV vaccination.  
  Univariate analysis  Multivariate logistic analysis 
   
Intention to take HPV vaccination 
 Intention to take HPV vaccination 
Yes vs. No 
A. Socio demographic 
characteristics 
Frequency 
(%) 
Yes 
(n = 1366) 
No 
(n = 1457) 
2 
p-value 
 Adjusted odds ratio (95% CI) 
Age (years old)       
13 2699 (95.6) 1235 (49.1) 1374 (50.9) p<0.000  0.60 (0.25 - 1.42) 
  14 124 (4.4) 41 (33.1) 83 (66.9)   Reference 
Ethnicity       
  Malay 1788 (63.3) 970 (54.3) 818 (45.7)   1.63 (0.38 - 6.94) 
  Chinese 661 (23.4) 215 (32.5) 446 (67.5)   0.67 (0.12 - 3.74) 
  Indian 131 (4.6) 79 (60.3) 52 (39.7) p<0.000  1.59 (0.21 - 11.96) 
  Aborigines 211 (7.5) 91 (43.1) 120 (56.9)   1.06 (0.24 - 4.70) 
  Others 32 (1.1) 11 (34.4) 21 (65.6)   Reference 
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Religion       
  Islam 1869 (66.2) 1009 (54.0) 860 (46.0)   0.98 (0.47 - 2.04) 
  Buddhism 552 (19.6) 178 (32.2) 374 (67.8)   0.881 (0.35 - 2.20) 
  Taoism 49 (1.7) 15 (30.6) 34 (69.4) 0.000  0.61 (0.17 - 2.17) 
  Hinduism 109 (3.9) 68 (62.4) 41 (37.6)   1.57 (0.35 - 6.98) 
  Christianity 234 (8.3) 90 (38.5) 144 (61.5)   Reference 
  Others
†
 10 (0.4) 6 (60.0) 4 (40.0)    
Religious status (n = 2781)       
  Very religious 632 (22.7) 319 (50.5) 313 (49.5)    
  Moderately religious 2046 (73.6) 969 (47.4) 1077 (52.6) 0.376   
  Not at all religious 103 (3.7) 51 (49.5) 52 (50.5)    
Mother’s Occupation (n = 2682) 342 (12.8)      
  Professional 466 (17.4) 169 (49.4) 173 (50.6)    
  Managerial 466 (16.5) 232 (49.8) 234 (50.2) 0.510   
  Skilled worker 217 (8.1) 110 (50.7) 107 (49.3)    
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  Housewife 1657 (61.8) 777 (46.9) 880 (53.1)    
Father’s occupation (n = 2509)       
  Professional 488 (19.4) 242 (49.6) 246 (50.4)    
  Managerial 992 (39.5) 475 (47.9) 517 (52.1) 0.829   
  Skilled worker 950 (37.9) 449 (47.3) 501 (52.7)    
  Unemployed 79 (3.1) 36 (45.6) 43 (54.4)    
Monthly average household 
income (MYR; n = 2687) 
      
  ≤ 1000 858 (31.9) 414 (48.3) 444 (51.7)    
  1001 – 2000 617 (23.0) 306 (49.6) 311 (50.4)    
  2001 – 3000 407 (15.1) 202 (49.6) 205 (50.4) 0.808   
  3001 – 4000 319 (11.9) 151 (47.3) 168 (52.7)    
  > 4000 486 (18.1) 225 (46.3) 261 (53.7)    
Location of school       
  Urban 1805 (63.9) 839 (46.5) 966 (53.5)   Reference 
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  Rural 1018 (36.1) 527 (51.8) 491 (48.2) 0.008  1.49 (1.14 - 1.95)** 
 
B. HPV knowledge        
Total HPV knowledge score (n 
= 1209)  
      
  0 – 3 658 (42.2) 381(57.9) 277 (42.1) 0.953   
  4 – 10 551 (57.8) 318 (57.7) 233 (42.3)    
C. Health belief        
General health belief       
HPV vaccine is good for health 
just like all other vaccine (n = 
1181) 
      
  Agree 586 (49.6) 337 (57.5) 249 (42.5) 0.953   
 Disagree/ Don’t know 595 (50.4) 344 (57.8) 251 (42.2)    
Taking the HPV vaccine is a       
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good idea because it is 
recommended by the 
government (n = 1179) 
  Agree 656 (55.6) 379 (57.8) 277 (42.2) 1.000   
  Disagree/ Don’t know 523 (44.4) 303 (57.9) 220 (42.1)    
Perceived benefit       
The HPV vaccine would be a 
good way to prevent HPV 
infection (n = 1182) 
      
  Agree 717 (60.7) 393 (54.8) 324 (45.2) 0.016  0.91 (0.70 - 1.18) 
Disagree/ Don’t know 465 (39.3) 288 (61.9) 177 (38.1)   Reference 
Perceived susceptibility       
Do you think you will get 
infected with HPV? (n = 1183) 
      
  Agree 110 (9.3) 74 (67.3) 36 (32.7) 0.034  1.63 (1.06 - 2.52)* 
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  Disagree/ Don’t know 1073 (90.7) 608 (56.7) 465 (43.3)   Reference 
Feeling of worry       
I am worry about getting 
infected with HPV (n = 1182) 
      
  Agree 472 (39.9) 276 (58.5) 196 (41.5) 0.674   
  Disagree 710 (60.1) 406 (57.2) 304 (42.8)    
Perceived severity       
Infection with HPV can lead to 
serious illness (n = 1183) 
      
  Agree 516 (43.6) 298 (57.8) 218 (42.2) 0.953   
  Disagree/ Don’t know 667 (56.4) 384 (57.6) 283 (42.4)    
Perceived barriers       
Getting vaccines are scary and 
painful (n = 1183) 
      
  Agree 259 (21.9) 141 (54.4) 118 (45.6) 0.255   
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  Disagree/ Don’t know 924 (78.1) 541 (58.5) 383 (41.5)    
Attitudes        
Boys do not need to be 
vaccinated, only girls should 
receive the vaccine (n = 1181) 
      
  Agree 474 (40.1) 227 (47.9) 247 (52.1) 0.000  Reference 
  Disagree/ Don’t know 707 (59.9) 454 (64.2) 253 (35.8)   2.05 (1.57 - 2.68)*** 
HPV vaccines is not safe for me 
(n = 1180) 
      
  Agree 184 (15.6) 99 (53.8) 85 (46.2) 0.256   
  Disagree/ Don’t know 996 (84.4) 582 (58.4) 414 (41.6)    
I dont think HPV vaccine will 
prevent HPV infection (n = 
1175) 
      
  Agree 197 (16.8) 115 (58.4) 82 (41.6) 0.753   
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  Disagree/ Don’t know 978 (83.2) 558 (57.1) 420 (42.9)    
HPV vaccine may encourage 
peeople to have sex at an early 
age(n = 1179) 
      
  Agree 142 (12.0) 80 (56.3) 62 (43.7) 0.856   
  Disagree/ Don’t know 1037 (88.0) 596 (57.5) 441 (42.5)    
HPV vaccine may encourage 
people to have multiple sexual 
partners (n = 1177) 
      
  Agree 132 (11.2) 80 (60.6) 52 (39.4) 0.456   
  Disagree/ Don’t know 1045 (88.8) 596 (57.0) 449 (43.0)    
My parents might not allow me 
to get the HPV vaccine (n = 
1180) 
      
  Agree 184 (15.4) 81 (44.0) 103 (56.0) 0.000  Reference 
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‡
Responses less than total number who had heard of HPV or HPV vaccination (n = 1209) due to lower response rate 
†
 Not included in multivariate analysis due to small sample 
*p value < 0.05, ** p value < 0.01, ***p value < 0.001 
Hosmer and Lemeshow test; chi-square:8.087, p-value: 0.425, Nagelkerke R square: 0.099 
  Disagree/ Don’t know 996 (84.4) 596 (59.8) 400 (40.2)   1.66 (1.18 - 2.34)** 
My religion prohibits me from 
receiving HPV vaccine because 
it is sexual related (n = 1180) 
      
  Agree 101 (8.6) 64 (63.4) 37 (36.6) 0.208   
  Disagree/ Don’t know 1079 (91.4) 612 (56.7) 467 (43.3)    
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